David J Nusbaum, Zhuqing Shi, Annabelle Ashworth, Huy Tran, Jun Wei, Aaron S Dahmen, Piyush K Agarwal, Craig V Labbate, Brian T Helfand, Jianfeng Xu
{"title":"A polygenic risk score is associated with risk of bladder cancer and earlier age of diagnosis, independent of lifestyle factors.","authors":"David J Nusbaum, Zhuqing Shi, Annabelle Ashworth, Huy Tran, Jun Wei, Aaron S Dahmen, Piyush K Agarwal, Craig V Labbate, Brian T Helfand, Jianfeng Xu","doi":"10.1016/j.urolonc.2025.05.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Genetic risk factors are not currently incorporated into the clinical evaluation of patients at risk for bladder cancer (BCa). The objective of this study is to assess the independent and joint effects of genetic and lifestyle factors on the risk of developing BCa and age at diagnosis.</p><p><strong>Methods: </strong>This is a population-based cohort study of the UK Biobank, consisting of 3,373 BCa cases and 481,275 controls. A polygenic risk score (PGS) was calculated and the effect of lifestyle and genetic factors on BCa risk was estimated using hazard ratio (HR).</p><p><strong>Results: </strong>The PGS was a significant and independent predictor of the risk of BCa diagnosis. Compared to never-smokers with BMI <30 and a PGS in the lowest decile, current smoking was associated with a HR of 4.47 (95% CI 3.35-5.98) and a PGS in the highest decile was associated with a HR of 4.57 (95% CI 3.44-6.09). Risk was highest for current smokers with BMI ≥30 and a PGS in the highest decile (HR 8.14, 95% CI 4.95-13.36). Most study subjects (∼95%) were of European ancestry.</p><p><strong>Conclusion: </strong>The PGS was an independent and significant predictor of the risk of BCa and earlier age at diagnosis. The effect size of PGS in the highest decile was similar to that of smoking. Joint effects were observed with smoking status and BMI. These data provide support for incorporating measures of genetic risk factors in efforts to improve early detection of BCa.</p>","PeriodicalId":23408,"journal":{"name":"Urologic Oncology-seminars and Original Investigations","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology-seminars and Original Investigations","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2025.05.009","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Genetic risk factors are not currently incorporated into the clinical evaluation of patients at risk for bladder cancer (BCa). The objective of this study is to assess the independent and joint effects of genetic and lifestyle factors on the risk of developing BCa and age at diagnosis.
Methods: This is a population-based cohort study of the UK Biobank, consisting of 3,373 BCa cases and 481,275 controls. A polygenic risk score (PGS) was calculated and the effect of lifestyle and genetic factors on BCa risk was estimated using hazard ratio (HR).
Results: The PGS was a significant and independent predictor of the risk of BCa diagnosis. Compared to never-smokers with BMI <30 and a PGS in the lowest decile, current smoking was associated with a HR of 4.47 (95% CI 3.35-5.98) and a PGS in the highest decile was associated with a HR of 4.57 (95% CI 3.44-6.09). Risk was highest for current smokers with BMI ≥30 and a PGS in the highest decile (HR 8.14, 95% CI 4.95-13.36). Most study subjects (∼95%) were of European ancestry.
Conclusion: The PGS was an independent and significant predictor of the risk of BCa and earlier age at diagnosis. The effect size of PGS in the highest decile was similar to that of smoking. Joint effects were observed with smoking status and BMI. These data provide support for incorporating measures of genetic risk factors in efforts to improve early detection of BCa.
期刊介绍:
Urologic Oncology: Seminars and Original Investigations is the official journal of the Society of Urologic Oncology. The journal publishes practical, timely, and relevant clinical and basic science research articles which address any aspect of urologic oncology. Each issue comprises original research, news and topics, survey articles providing short commentaries on other important articles in the urologic oncology literature, and reviews including an in-depth Seminar examining a specific clinical dilemma. The journal periodically publishes supplement issues devoted to areas of current interest to the urologic oncology community. Articles published are of interest to researchers and the clinicians involved in the practice of urologic oncology including urologists, oncologists, and radiologists.